Blog

Vertex Pharmaceuticals (NASDAQ: VRTX) and CRISPR Therapeutics (NASDAQ: CRSP) each have their own strengths. Vertex has developed a blockbuster portfolio of cystic fibrosis (CF) treatments. CRISPR is

Sundial Growers (NASDAQ: SNDL) has been a popular stock with retail investors this year. They were behind the company's rapid ascension in early February when its share price peaked at $3.96

Many drugmakers suffered at the height of the pandemic as sales volumes for prescription drugs decreased. Pharma giant Merck (NYSE: MRK) was one of those companies that saw financial results took a

There's a good chance that you'll need additional income in retirement. Social Security, for example, will probably deliver less income than you expect. The average monthly retirement benefit is

When it comes to contentious stocks, Ocugen (NASDAQ: OCGN) is likely one of the market's leaders. The company is trying to commercialize its coronavirus vaccine candidate and it also boasts

Social media has already changed the world, but its transformative impact is likely just getting started. Emerging technologies including augmented reality (AR) and the metaverse stand to change how

I'm still excited about the long-term prospects of the online lender OppFi (NYSE: OPFI), which is looking to significantly transform the subprime lending space. I particularly like the company's

Cannabis producer Tilray (NASDAQ: TLRY) is the industry leader in the Canadian pot market. Its low-cost operations have allowed the company to post a stronger bottom line than many of its peers

There's a reason investors are urged to diversify their portfolios rather than rely heavily on a handful of stocks or just one or two market segments. A wide mix of stocks could be the ticket to

Intuitive Surgical (NASDAQ: ISRG) InMode (NASDAQ: INMD) are both technology-intensive companies that are aggressive disruptors in their respective healthcare markets, and the similarities don't end

Looking for a way to hedge against runaway inflation? Here's one you might not have considered yet.

Small-cap stocks tied to nimble businesses that can quickly pivot during times of crisis are

For more than a century, the stock market has sat atop the investment pedestal. Although the broad-based S&P 500 doesn't top bonds, gold, or housing every year, it's delivered the highest average

Fulgent Genetics (NASDAQ: FLGT) ranks as one of the fastest-growing genetic testing companies around. But the company faces plenty of rivals. In this Motley Fool Live video recorded on Nov. 10

In 2022, the average Social Security retirement benefit will be $1,657 per month. An annual retirement benefit of just $19,884 isn't particularly generous and doesn't come close to covering the

Most of us wish we had invested in -- or invested more in -- Bitcoin. The world's first cryptocurrency started out at around eight cents in 2010. And this year, it surpassed $60,000. Of course, it

Today's video focuses on Nvidia (NASDAQ:NVDA) CEO Jensen Huang's excitement about artificial intelligence (AI) avatars, and how he believes the virtual robotics application will likely be the most

In case you haven't been paying attention to Amazon (NASDAQ: AMZN) for the last half-decade, it's been building a massive logistics network across the United States. And even while sales slowed for

Folks, I've got some good news and some "bad news," depending on your perspective.

On the bright side, the benchmark S&P 500 (SNPINDEX: ^GSPC) has enjoyed a historic bounce-back rally from its March

If you have access to a workplace 401(k), this account can help you save for retirement due to the generous tax breaks it offers. Your company may also provide you with matching contributions, which

Earlier this year, seniors on Social Security got some pretty good news. Next year, Social Security benefits will be eligible for a 5.9% cost-of-living adjustment (COLA), leaving seniors with their

Shares of Nvidia (NASDAQ: NVDA) climbed 4% on Friday, as optimism for the chipmaker's data center opportunity and Omniverse initiatives continued to build among investors. 

Following the semiconduct

Shares of Moderna (NASDAQ: MRNA) climbed 5% on Friday after U.S. health regulators took steps toward making COVID-19 booster vaccines available for more Americans. 

The U.S. Food and Drug

Apple (NASDAQ: AAPL) was a popular stock on Friday, rising by nearly 2% against the slight dip in the S&P 500 index to finish at a new all-time high of over $160 per share. That move upward came on

The stock market had a strange day on Friday, as pockets of the market performed quite well while others took fairly large hits. More extreme measures to control the COVID-19 pandemic overseas have

Ocugen (NASDAQ: OCGN), one of the more talked-about meme stocks in the biotech sector, closed out this week on a high note. The company's shares flew more than 6% higher, on the back of generally